Mark C. Capone
2017
In 2017, Mark C. Capone earned a total compensation of $5.2M as President and Chief Executive Officer at Myriad Genetics, a 6% increase compared to previous year.
Compensation breakdown
| Bonus | $307 |
|---|---|
| Non-Equity Incentive Plan | $741,240 |
| Salary | $852,000 |
| Stock Awards | $3,613,500 |
| Other | $10,848 |
| Total | $5,217,895 |
Capone received $3.6M in stock awards, accounting for 69% of the total pay in 2017.
Capone also received $307 in bonus, $741.2K in non-equity incentive plan, $852K in salary and $10.8K in other compensation.
Rankings
In 2017, Mark C. Capone's compensation ranked 1,770th out of 14,666 executives tracked by ExecPay. In other words, Capone earned more than 87.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,770 out of 14,666 | 88th |
Division Manufacturing | 591 out of 5,770 | 90th |
Major group Chemicals And Allied Products | 155 out of 2,074 | 93rd |
Industry group Drugs | 111 out of 1,730 | 94th |
Industry In Vitro and In Vivo Diagnostic Substances | 3 out of 72 | 96th |
Source: SEC filing on October 12, 2017.
Capone's colleagues
We found four more compensation records of executives who worked with Mark C. Capone at Myriad Genetics in 2017.